• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

2 Huge Earnings Reports I'm Watching This Week

A pair of earnings report this week will shed light on the future direction of two fast-growing companies in very different fields.
By DAVE BUTLER
Apr 14, 2019 | 09:03 AM EDT
Stocks quotes in this article: APHA, CGC, STZ, NFLX, DIS

With the new earnings season heating up, this week is a big one for me.

I own shares of Canadian cannabis company Aphria Inc. (APHA) , and have been following the developing streaming wars between names such as Netflix, Inc. (NFLX) and The Walt Disney Co. (DIS) .

It will be interesting to see where the focus rests within Netflix's earnings. Will investors begin to look at earnings and cash flow versus user growth? Or will the emphasis on subscriptions continue to rule the day?

Aphria (April 15)

I own Aphria Inc. (APHA) , but do not expect much in the company's fiscal third quarter 2019 earnings release.

I don't think there's been enough time for Canadian cannabis firms to put together the sales necessary to show us much in profits. There were likely still a great many costs incurred in the quarter as these companies try to finalize their production goals and expansions.

Estimates are showing a loss of $0.04 per share for Aphria. While that certainly wouldn't be the biggest nightmare in relation to other names within the marijuana industry, it's still a tough sell when you look at the share pricing.

The catch here is that these stocks simply aren't value based at all. They're all speculative growth plays.

I have traded Aphria a few times. It piqued my interest because it was one of the first medical marijuana companies that was actually profitable. The losses only kicked in after the company began the expensive process of creating a supply of the scale needed for recreational sales. Even now, there is talk of many shortages within the market, and I think Aphria has more room to go.

I won't sell my position if these earnings disappoint. I don't think there's been enough time for producers to really see the benefits of full scale yet. If anything, I might add to my position if things take a hit.

Aphria has lost favor with some due to its drama over short-seller accusations, and the exit of key executives. Personally, I think the production capacity being put together by Aphria makes it one of the more promising names. Canopy Growth Corp. (CGC) has certainly taken center stage after its huge cash infusions from Constellation Brands, Inc. (STZ) , but I remain interested in seeing what happens with Aphria as the recent controversies slowly fade away.

Netflix (April 16)

The timing of this earnings release is rather dicey for Netflix. Disney's announcement of its own streaming service launching in November is a real problem for morale. I've said before that Netflix needed to take advantage of its head start as a streaming service. It has failed to do so in terms of creating a profitable enterprise from a cash-flow perspective.

Whereas past earnings reports have revolved around user growth, I have a feeling this might be the first quarter where valuations or cash flow begin to punch the stock price. Netflix has created unquestionably strong content, in my opinion. The problem is the cash flow involved in creating great programming has been too great. As more players begin to venture into streaming in a big way, it begs the question of whether Netflix's spending will keep drawing in new-user growth.

That's the big thing here. Netflix has always been about scaling itself through providing great content in order to create large-scale profitability down the road. While the company has found profits, and is expected to report $0.56 per share in the first quarter, that would mark a decline from last year's $0.64 per share. On top of that, Netflix's previous guidance suggests that we're still going to see weak cash flow. All of this might not be such a big deal if the stock wasn't facing higher competition.

You can see the toll that a P/E of over 100 is taking on the stock, as the shares were down over 4% Friday reacting to news of Disney's announced streaming initiatives. Let's not forget Disney also controls the majority share of rising service Hulu. It's a big problem for Netflix, and I expect the story will become ever more pervasive in the coming quarters.

Disney has proven its ability to derive big profits from its content creation. One might even argue they're the best at it. I think Disney's announcement is going to take some real wind out NFLX this week, unless the company manages to show surprise numbers on both user growth as well as earnings.

Looking past this sole earnings release, we still face the prospect of a hardcore content war erupting between these two names as well as others.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Butler was long APHA

TAGS: Earnings | Fundamental Analysis | Investing | Marijuana | Media | Movies | Television Production/Distribution | Canada | Cannabis

More from Investing

Traders: Keep Your Fingers on the Trigger and Targets on a Bottom

James "Rev Shark" DePorre
Mar 4, 2021 4:39 PM EST

As the correction goes on, here's what to do now.

There's Nothing Pleasant About the Current Action

Timothy Collins
Mar 4, 2021 3:00 PM EST

The next good sized bounce in SPAC names, and maybe ARKK names, might be the last exit off the bagholder highway.

Royal Caribbean Is Getting Called Back to Port

Bruce Kamich
Mar 4, 2021 3:00 PM EST

Has the reopening news already been priced in? The charts are telling investors to look out ahead.

Nike's Charts and Indicators Are Still Bearish

Bruce Kamich
Mar 4, 2021 2:20 PM EST

Avoid the long side.

Listen to Mr. Market, Not Mr. Powell

Jim Collins
Mar 4, 2021 1:56 PM EST

Let's look at bonds, rates and, especially, inflation for a true picture of what's going on, and where to put your money.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 10:53 AM EST GARY BERMAN

    Nasdaq Composite: Some Backing and Filling Is Here

    As today is the 4th day of the month, it seems lik...
  • 07:59 AM EST PAUL PRICE

    Fabulous News on United Natural Foods (UNFI)

    The major potential risk factor for , its contrac...
  • 08:50 AM EST PAUL PRICE

    Michaels: Close to a Deal?

    It appears that a deal could be announced soon. ...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login